For Researchers

MAR Platform

Traditional recruitment takes months. Your research window shouldn't close before you have enough participants to matter.

Request early access See what's inside

Your participants are out there. Maia connects you directly.

Autoimmune research has always been hampered by fragmented data, slow ethical recruitment, and participants who disengage before studies complete. The insights you need exist — but the bridge to reach them hasn't.

MAR connects directly to Maia Health, giving researchers access to thousands of actively engaged autoimmune patients. Consent-based, GDPR-compliant, and designed for real longitudinal science from day one.

Research without
friction

Active Studies

Research Workspace

Live recruitment dashboard.

Dietary Triggers Study847 participants

Recruiting

Biologics Response1,203 participants

Analyzing

Microbiome Correlation156 participants

Processing

Stress-Flare Series2,041 participants

Active

Sleep & Disease Activity678 participants

Analyzing

N = 2,041

Real-World Evidence

Significant correlation between sleep latency and inflammatory flares — detected across 2,041 participants.

P-value < 0.001Lag: 72h window

Completion Rates

Longitudinal89%

Observational76%

Survey-based94%

Export Ready

Publication Dataset

Validated, anonymized dataset ready for peer-reviewed submission. GDPR-compliant export with full provenance.

Download Dataset

How MAR works

From protocol to publication — designed to eliminate every friction point.

Design

Build your study protocol with our flexible study builder. Surveys, observational studies, longitudinal tracking.

Deploy

Reach thousands of consenting Maia Health patients who match your inclusion criteria in real time.

Collect

Real-world data streams in as participants engage. Longitudinal, structured, and GDPR-compliant from day one.

Publish

Export validated datasets and generate publication-ready reports with full provenance and anonymization.

Supported study types

MAR adapts to your research methodology. Design studies that match your scientific question — not the other way around.

Cross-sectional surveys

Longitudinal observational

Patient-reported outcomes

Symptom-trigger mapping

Treatment response tracking

Environmental exposure studies

Multi-cohort comparisons

Biomarker-symptom correlation

Quality of life assessments

Drug adherence monitoring

Flare prediction modelling

and more...

Questions? We have answers.

MAR launches in 2027. We are currently in closed beta with select academic and pharma partners. Request early access through our contact form to join the programme.

All patient data access is consent-based, anonymised, and GDPR/HIPAA compliant. Patients explicitly opt in to research participation through Maia Health, controlling exactly which studies they join and what data they share.

Yes. MAR offers academic pricing tiers designed for individual investigators and small labs. Enterprise features scale with the needs and budget of larger institutions and pharma partners.

MAR exports in standard formats: CSV, JSON, and structured FHIR-compatible datasets. Our API also supports integration with common bioinformatics pipelines and statistical environments.

Maia Health collects structured, longitudinal data with validation at point of entry. Participants engage daily, producing high-quality time-series data — not one-off surveys. MAR includes built-in quality scoring for every dataset.

Researchers retain full ownership of their study data and any resulting discoveries. Neural Omega provides the infrastructure and patient access. We never claim IP on research outputs.

Your next breakthrough is already in the data.

Join the researchers designing studies that matter — backed by the world's most engaged autoimmune patient community.

Request early access Pharma & Institutions →